Xenetix 300mg I/ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

xenetix 300mg i/ml solution for injection

guerbet - iobitridol - solution for injection - 300 milligram(s)/millilitre - watersoluble, nephrotropic, low osmolar x-ray contrast media; iobitridol

Xenetix 350mg I/ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

xenetix 350mg i/ml solution for injection

guerbet - iobitridol - solution for injection - 350 milligram(s)/millilitre - watersoluble, nephrotropic, low osmolar x-ray contrast media; iobitridol

Biliscopin For Infusion 10.5g/100mL injection bottle Australia - English - Department of Health (Therapeutic Goods Administration)

biliscopin for infusion 10.5g/100ml injection bottle

bayer australia ltd - iotroxate meglumine, quantity: 105.46 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; sodium bicarbonate; sodium chloride; water for injections - biliscopin for infusion is indicated for radiological examination of hepatic and biliary ducts and gallbladder when examination by oral technique is unsuccessful or inappropriate.

Leukeran 5mg Tablets Australia - English - Department of Health (Therapeutic Goods Administration)

leukeran 5mg tablets

aspen pharmacare australia pty ltd - chlorambucil, quantity: 5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; pregelatinised maize starch; sucrose; quinoline yellow; magnesium stearate - treatment of hodgkin's disease, certain forms of non-hodgkin's lymphoma, chronic lymphocytic leukaemia, waldenstrom's macroglobulinaemia, advanced ovarian adenocarcinoma. leukeran has a significant effect in a proportion of patients with breast cancer.

FLEBOGAMMA 5 % DIF Israel - English - Ministry of Health

flebogamma 5 % dif

medici medical ltd, israel - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 0.5 g / 10 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in: primary immunodeficiency syndromes such as:- congenital agammaglobulinaemia and hypogammaglobulinaemia- common variable immunodeficiency- severe combined immunodeficiency- wiskott aldrich syndromemyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.children with congenital aids and recurrent infections.immunomodulation :idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.guillain barré syndrome.kawasaki disease.allogeneic bone marrow transplantation

HEPATECT CP Israel - English - Ministry of Health

hepatect cp

kamada ltd, israel - human hepatitis b immunoglobulin - solution for infusion - human hepatitis b immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - prophylaxis against hepatitis b in adults and children over 2 years of age who have not been vaccinated against hepatitis b (including persons whose vaccination is incomplete or missing) who are at risk of infection with hepatitis b by accidental contact with hepatitis b virus containing material following: - percutaneous exposure (e.g. accidental needle stick). - direct mucous membrane contact. when the administration of an intramuscular hepatitis b immunoglobulin is not possible. the immunoglobulin should be administered in association with hepatitis b vaccine. prophylaxis against re-infection of a transplanted liver in patients who carry the surface antigen of the hepatitis b virus. immunoprophylaxis of hepatitis b in the newborn of a hepatitis b virus carrier mother.

GAMUNEX  - C Israel - English - Ministry of Health

gamunex - c

padagis israel agencies ltd, israel - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).

PRIVIGEN Israel - English - Ministry of Health

privigen

csl behring ltd., israel - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 100 g/l - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in• primary immunodeficiency syndromes (pid) such as: – congenital agammaglobulinaemia and hypogammaglobulinaemia – common variable immunodeficiency – severe combined immunodeficiency – wiskott-aldrich syndrome• myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections• children with congenital aids and recurrent infectionsimmunomodulation• immune thrombocytopenic purpura (itp) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count• guillain-barré syndrome• kawasaki disease• chronic inflammatory demyelinating polyneuropathy (cidp)allogeneic bone marrow transplantation

ALKERAN TABLETS 2 MG Israel - English - Ministry of Health

alkeran tablets 2 mg

padagis israel agencies ltd, israel - melphalan - tablets - melphalan 2 mg - melphalan - melphalan - for the treatment of : multiple myeloma and advanced ovarian adenocarcinoma